Back
Johnson & Johnson Vs. Lyra Therapeutics, Inc. Sector Stock Comparison
Buy
54
JNJ
Johnson & Johnson
Last Price:
$207.79
Seasonality Move:
1.72%
Sell
26
LYRA
Lyra Therapeutics, Inc.
Last Price:
$3.58
Seasonality Move:
3.74%
Buy
54
Johnson & Johnson (JNJ)
is a Buy
Is Johnson & Johnson a Buy, Sell or Hold?
-
The current Johnson & Johnson [JNJ] share price is $207.78. The Score for JNJ is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
JNJ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Lyra Therapeutics, Inc. (LYRA)
is a Sell
Is Lyra Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Lyra Therapeutics, Inc. [LYRA] share price is $3.58. The Score for LYRA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $207.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JNJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYRA Stock Price Chart
What is Lyra Therapeutics, Inc.'s stock price today?
-
The Lyra Therapeutics, Inc. share price today is $3.58Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing slight selling pressure.
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.62 | Buy |
| Relative Strength Index (14 RSI): | 56.98 | Buy |
| Chaikin Money Flow: | 2055658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (202.98 - 209.52) | Buy |
| Bollinger Bands (100): | (176.86 - 201.04) | Buy |
LYRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 39.44 | Sell |
| Chaikin Money Flow: | -567 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.35 - 4.09) | Sell |
| Bollinger Bands (100): | (4.32 - 7.28) | Sell |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 208.67 | Sell |
| 20-day SMA: | 206.7 | Buy |
| 50-day SMA: | 198.72 | Buy |
| 200-day SMA: | 173.03 | Buy |
| 8-day EMA: | 207.56 | Buy |
| 20-day EMA: | 205.92 | Buy |
| 50-day EMA: | 199.42 | Buy |
| 200-day EMA: | 179.2 | Buy |
LYRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.72 | Sell |
| 20-day SMA: | 3.83 | Sell |
| 50-day SMA: | 4.68 | Sell |
| 200-day SMA: | 7.03 | Sell |
| 8-day EMA: | 3.72 | Sell |
| 20-day EMA: | 3.88 | Sell |
| 50-day EMA: | 4.59 | Sell |
| 200-day EMA: | 10.55 | Sell |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.67 per share.
Lyra Therapeutics, Inc. Earnings Growth & LYRA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $62.25 per share, and an increase next year of $0.51 per share.
Johnson & Johnson Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyra Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||